PortfoliosLab logoPortfoliosLab logo
Privia Health Group, Inc. (PRVA)
Performance
Return for Risk
Dividends
Drawdowns
Volatility
Financials

Company Info

ISIN
US74276R1023
CUSIP
74276R102
IPO Date
Apr 28, 2021

Highlights

Market Cap
$2.68B
Enterprise Value
-$465.27B
EPS (TTM)
$70.94
PE Ratio
0.29
PEG Ratio
0.00
Total Revenue (TTM)
$542.75B
Gross Profit (TTM)
$154.43M
EBITDA (TTM)
$14.63B
Year Range
$18.77 - $26.51
Target Price
$30.86
ROA (TTM)
0.67%
ROE (TTM)
1.24%

Share Price Chart


Loading graphics...

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Privia Health Group, Inc.

Often compared with PRVA:
PRVA vs. COSTPRVA vs. OPCH

Performance

Performance Chart

The chart shows the growth of an initial investment of $10,000 in Privia Health Group, Inc., comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


Loading graphics...

S&P 500 Index

Returns By Period

Privia Health Group, Inc. (PRVA) has returned -13.24% so far this year and -8.37% over the past 12 months.


Privia Health Group, Inc.

1D
2.75%
1M
-13.39%
YTD
-13.24%
6M
-17.39%
1Y
-8.37%
3Y*
-9.35%
5Y*
10Y*

Benchmark (S&P 500 Index)

1D
2.91%
1M
-5.09%
YTD
-4.63%
6M
-2.39%
1Y
16.33%
3Y*
16.69%
5Y*
10.18%
10Y*
12.16%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Monthly Returns

Based on dividend-adjusted daily data since Apr 28, 2021, PRVA's average daily return is +0.05%, while the average monthly return is +0.85%. At this rate, your investment would double in approximately 6.8 years.

Historically, 48% of months were positive and 52% were negative. The best month was Apr 2021 with a return of +57.9%, while the worst month was Nov 2022 at -28.5%. The longest winning streak lasted 4 consecutive months, and the longest losing streak was 4 months.

On a daily basis, PRVA closed higher 48% of trading days. The best single day was Apr 29, 2021 with a return of +51.1%, while the worst single day was May 6, 2021 at -13.7%.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
2026-2.07%2.28%-13.39%-13.24%
202516.88%9.28%-10.09%4.59%-3.07%1.05%-15.13%18.03%8.07%-2.41%0.29%-2.71%21.28%
2024-12.46%10.71%-12.23%-6.07%-5.60%0.06%19.33%-2.89%-9.58%0.82%16.99%-8.99%-15.11%
202319.07%3.29%-1.15%0.07%-9.70%4.65%6.93%-5.98%-12.38%-8.61%-1.71%11.47%1.41%
2022-17.74%20.96%3.85%-17.73%8.96%21.54%26.30%8.18%-14.40%-1.70%-28.52%-5.10%-12.21%
202157.91%-9.88%35.56%-6.47%-28.17%-20.97%9.08%-10.12%11.99%12.48%

Benchmark Metrics

Privia Health Group, Inc. has an annualized alpha of 1.14%, beta of 1.06, and R² of 0.11 versus S&P 500 Index. Calculated based on daily prices since April 29, 2021.

  • This stock participated in 67.87% of S&P 500 Index downside but only 28.29% of its upside — more exposed to losses than it benefited from rallies.
  • R² of 0.11 means this stock moves largely independently of S&P 500 Index — capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

Alpha
1.14%
Beta
1.06
0.11
Upside Capture
28.29%
Downside Capture
67.87%

Return for Risk

Risk / Return Rank

PRVA ranks 28 for risk / return — below 28% of stocks on our site. The returns aren't fully compensating for the risk involved. This isn't necessarily a dealbreaker, but factor it into your decision — especially if you're risk-averse.


PRVA Risk / Return Rank: 2828
Overall Rank
PRVA Sharpe Ratio Rank: 2929
Sharpe Ratio Rank
PRVA Sortino Ratio Rank: 2525
Sortino Ratio Rank
PRVA Omega Ratio Rank: 2626
Omega Ratio Rank
PRVA Calmar Ratio Rank: 2929
Calmar Ratio Rank
PRVA Martin Ratio Rank: 2828
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

Return / Risk — by metrics

The table below present risk-adjusted performance metrics for Privia Health Group, Inc. (PRVA) and compare them to a chosen benchmark (S&P 500 Index).


PRVABenchmarkDifference

Sharpe ratio

Return per unit of total volatility

-0.25

0.90

-1.15

Sortino ratio

Return per unit of downside risk

-0.15

1.39

-1.54

Omega ratio

Gain probability vs. loss probability

0.98

1.21

-0.23

Calmar ratio

Return relative to maximum drawdown

-0.36

1.40

-1.76

Martin ratio

Return relative to average drawdown

-0.75

6.61

-7.35

Explore PRVA risk-adjusted metrics in detail

Dive deeper into individual metrics with historical trends, benchmark comparisons, and performance across different time periods.

Dividends

Dividend History


Privia Health Group, Inc. doesn't pay dividends

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


Loading graphics...

Worst Drawdowns

The table below displays the maximum drawdowns of the Privia Health Group, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Privia Health Group, Inc. was 67.33%, occurring on May 20, 2024. The portfolio has not yet recovered.

The current Privia Health Group, Inc. drawdown is 58.23%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-67.33%Jun 29, 2021728May 20, 2024
-23.34%May 6, 20217May 14, 202117Jun 9, 202124
-4.25%Jun 24, 20211Jun 24, 20212Jun 28, 20213
-3.85%May 3, 20212May 4, 20211May 5, 20213
-2.02%Jun 15, 20211Jun 15, 20211Jun 16, 20212

Volatility

Volatility Chart

The chart below shows the rolling one-month volatility.


Loading graphics...

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Privia Health Group, Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.


Annual
Quarterly

0.0

Valuation

The Valuation section provides an overview of how Privia Health Group, Inc. is priced in the market compared to other companies in the Health Information Services industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.


PE Ratio

The chart displays the Price-to-Earnings (P/E) ratio for PRVA, comparing it with other companies in the Health Information Services industry. Currently, PRVA has a P/E ratio of 0.3. This P/E ratio is considered low compared to industry peers, which may suggest that the stock is undervalued or that the company has weaker growth prospects.

PEG Ratio

The chart shows the Price/Earnings to Growth (PEG) ratio for PRVA compared to other companies in the Health Information Services industry. PRVA currently has a PEG ratio of 0.0. This PEG ratio is low compared to industry peers, which could indicate the stock is undervalued relative to its expected growth.

PS Ratio

This chart shows the Price-to-Sales (P/S) ratio for PRVA relative to other companies in the Health Information Services industry. Currently, PRVA has a P/S ratio of 0.0. This P/S ratio is low compared to the industry average. It may indicate that the stock is undervalued relative to its revenue, or that the market expects slower growth or lower margins.

PB Ratio

The chart illustrates the Price-to-Book (P/B) ratio for PRVA in comparison with other companies in the Health Information Services industry. Currently, PRVA has a P/B value of 0.0. This P/B ratio is low compared to industry peers. It might indicate the stock is undervalued or that the company’s assets are not expected to generate strong returns.

Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items